INTRODUCTION
Ketotifen is a benzocycloheptathiophene derivative that has been shown to possess anti-histaminic and anti-anaphylactic properties [1] . It has been demonstrated that it can block in vitro release of mediators from rat peritoneal mast cells [1] . The drug inhibits the release of histamine and leukotriene from basophil and lung tissue, antagonizes histamine at H 1 receptors, inhibits calcium uptake, blocks passive cutaneous anaphylactic reaction, reverses isoprenalineinduced beta-adrenoceptor tachyphylaxis, and inhibits both allergen-induced and druginduced asthma [2] .
A number of clinical trials of ketotifen have shown it to have a beneficial effect in the treatment of asthma [3, 4] equivalent to that of disodium cromoglycate, which has an established place in the treatment of asthma [5, 6] . Ketotifen, which is useful in the treatment of hay fever and asthma, have been found to inhibit anaphylactic histamine release from animal tissues .
Theophylline, also known as dimethylxanthine, is a xanthine with bronchodilator properties and is used in the treatment of asthma and chronic obstruvtive pulmonary disease (COPD). Moreover, theophylline has been shown to have some anti-inflammatory activities, inhibiting the activity of CD4 lymphocytes in-vitro and mediator release from mast cells [7] . It also inhibits bronchoconstriction produced by exercise and challenge testing, and has also been shown to have beneficial effects on the contraction of the diaphragm, an effect which may be particularly useful in patients with COPD [8, 9] . Drug-drug interaction occurs when one therapeutic agent either alters the concentration (pharmacokinetic interactions) or the biological effect (pharmacodynamic interactions) of another agent [10] .The clinical significance of a specific drug-drug interaction depends on the degree of accumulation of the substrate and the therapeutic window of the substrate [11] . The combination of theophylline and ketotifen is often used for respiratory tract infection and some suggest the combination is effective [12] though others suggest the combination may be embryotoxic, with growth retardation, morphological abnormalities, etc [13] . The present study was designed to evaluate the interaction between ketotifen fumarate and anhydrous theophylline, as well as the safety of the combination therapy and their protein binding activity.
EXPERIMENTAL

Drugs and chemicals
Ketotifen fumarate (potency, 95%) and anhydrous theophylline (potency, 91%) were obtained from Square Pharmaceuticals Ltd, Dhaka, Bangladesh, as gifts, and used without further purification. Bovine serum albumin (fraction V) and semipermeable membrane (Medicell, England) were purchased from BDH (England). Sodium dihydrogen orthophosphate and di-sodium hydrogen orthophosphate, used for the preparation of buffer solutions were purchased from Merck, Germany. Potassium chloride, sodium hydroxide, potassium hydroxide and other reagents used were all of reagent grade.
Equipment
For the tests, we used UV-Visible spectrometer (model no. UV-1600, Shimadzu, Japan), pH meter (Mettler Toledo, Switzerland), analytical balance (model AL 204-S/01, Mettler Toledo, Switzerland), and a thermostatted water bath (Shimadzu, Japan). A Dunbuff metabolic shakimg incubator (Nickel, Electrical Company, England) was used to shake the plasma/drug mixtures to attain equilibrium.
Preparation of standard solutions
Stock solutions of ketotifen fumarate (1X10 -3 M) and anhydrous theophylline (1X10 -3 M) prepared by dissolving them in distilled water. These stock solutions were diluted to desired strengths (1X10 -5 M) by buffer solutions to obtain the working standard solutions.
Absorption spectrum analysis
The absorption characteristics of ketotifen fumarate and theophylline, separately, and their 1:1, 1:2 and 2:1 mixtures in HCl/NaCl buffer solutions (pH 0.4 and 2.0) and phosphate buffer (pH 6.0), respectively, were obtained and compared with those of each of the interacting species [14, 15] . The concentrations of the sample were kept at very dilute levels in each case and the measurements made using UV-VIS spectrophotometer with a constant temperature cell compartment and automatic recording unit. The stock solutions of the samples were diluted to appropriate levels with the respective buffers (1 x 10 -5 M) at the desired pH and the spectra recorded between 400 -190 nm. The spectra were compared with those of the pure samples in each case.
Job's spectrophotometric method
Based on Job's method [16] , a series of solutions were prepared in which the analytical concentration of one reactant (usually the cation) was held constant while that of the other was varied. Absorbance of series of mixtures of ketotifen fumarate and theophylline in varying molar ratios (1:9, 2:8, 3:7, 4:6, 5:5, 6:4, 7:3, 8:2, 9:1) were measured, keeping the total mole constant. The absorbance of each of the mixtures was subtracted from sum of the values for the free drugs. The absorbance difference (D) was then plotted against the mole fraction of the drug in the mixtures. If the two straight lines of different slopes that intersect at a mole ratio that corresponds to the combined ratio in the complex are obtained.
Ardon's spectrophotometric method [17] In this method [18] , the concentration of anhydrous theophylline was fixed (2 x 10 -4 M) while ketotifen concentration was varied. The absorbance of the free drug solutions and that of the mixtures were measured spectrophotometrically at 300 nm at different pH. Based on Ardon's equation (Eq 1), the 1/(D-Cǫ A ) was plotted against 1/drug, and the values of stability constant were calculated from the intercept/slope of the straight lines obtained.
where D = absorbance of the mixture; B = molar concentration of the ketotifen fumarate; C = molar concentration of the anhydrous theophylline; є com = molar extinction coefficient of the complex; and є A = molar extinction coefficient of the ketotifen fumarate
Equilibrium dialysis method
The semi-permeable membrane (Medicell, England) was activated by digesting with 1M NaHCO 3 at 70 0 C for 4 h, washed with deionised water and immersed in 0.067M phosphate buffer at pH 7.4. At first the membrane was cut into small pieces, 4 cm in length, and taken in a 500 ml beaker containing de-ionized water maintained at 65 -70 
Statistical analysis
The results are expressed as mean ± standard error of mean (SEM) values. Differences between the means of experimental data were analyzed by unpaired t-test. A probability value less than 0.05 (p < 0.05) was taken as significant.
RESULTS
Each of the drugs studied showed absorption in the UV-VIS region. The molecular species of ketotifen fumarate and theophylline, when mixed together, showed some changes in their absorption characteristics including shift in absorption maxima. The curves obtained by Job's method showed breaks at different molar concentrations for the drugs. The curve for pH 0.4 medium was exhibited downward movement to at pH 2 and 6 (see Figure 1) . 
DISCUSSION
Initial evidence for complexation of ketotifen fumarate with theophylline came from differences between the spectra of the drugs and those of their mixtures in buffer solutions. Each compound has its unique molecular structure or electronic configuration which is responsible for absorption of light. The spectra of ketotifen fumarate at different pH showed a sharp absorption maximum at 300 nm but when theophylline was mixed with it in 2:1 ratio at pH 0.4, the intensity of ketotifen peak changed remarkably as absorption decreased but the absorption of the compound did not shift at pH 0.4. At pH 6, the intensity of the peak of ketotifen was altered as absorption increased.
Very low stability constant values mean that the complex formed due to the interaction of the drugs readily dissociates, yielding essentially the drugs in ionic form, ranging from pH as low as stomach acid (pH 0.4 to 3) to as high as physiologic pH 6.0 (pH of main extracellular body fluids such as serum and lymph). The values of the stability constant, which varied between 5.07 and 6.35, indicate not only that complexation occured between ketotifen and theophylline but also that the interaction was pronounced. It can be assumed that these two drugs should not be co-administered.
In applying Ardon,s method, theophylline was taken as the parent drug, and in its interaction with ketotifen, lower stability constant values were found, indicating readily solubility of both drugs and minimum drugdrug interaction. The degree of protein binding of ketotifen decreased with increase in the concentration of theophylline attaining a steady (plateau) state when the free drug concentration was around 5 x 10 -5 M. On the other hand, the theophylline curve also declined significantly (p = 0.01) due to protein binding of ketotifen fumerate. .
CONCLUSION
Interaction of ketotifen with theophylline decreased the free drug concentration of both drugs which can result in decreased availability of the drugs at receptors. Ultimately, one or both drugs may show diminished pharmacologic activity. Furthermore, ketotifen fumarate and theophylline lowered protein binding of theophylline, could increase the volume of distribution of theophylline. Therefore, caution should be exercised during the administration of both drugs, pending in vivo experiments to determine the implication of our findings.
